Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Part of paid clinical trials in Hialeah, Florida.
- Sponsor
- Regeneron Pharmaceuticals
- Study ID
- NCT07493304
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Venous Thromboembolism (VTE)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- REGN7508 — DRUGAdministered per the protocol
- Apixaban — DRUGAdministered per the protocol
Study Details
This study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2. The study is focused on participants with or without cancer who develop blood clots in certain veins (called Deep Vein Thrombosis \[DVT\]) that block blood flow (Part 1) or focused on participants with cancer who develop blood clots in certain veins (DVT) or the lungs (also called Pulmonary Embolism \[PE\]) (Part 2). The aim of the study is to see how safe and effective the study drug is at treating and preventing further blood clots in participants with or without cancer (Part 1) or in participants with cancer (Part 2) compared with another treatment (apixaban). The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- May 2026
- Primary completion
- Jul 8, 2031
- Completion
- Jul 8, 2031
Study Design
- Enrollment
- 1,600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: REGN7508
- Active Comparator: Apixaban
Primary Outcome Measure
Occurrence of Treatment-Emergent Adverse Events (TEAEs) [ Time Frame: Approximately 6 months ]
Central Contacts
- Clinical Trials Administrator844-734-6643
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bioresearch Partner- Hialeah Hospital | Hialeah | Florida | 33013 | - |
| El Paso Medical Research Institute (Medresearch Inc) | El Paso | Texas | 79902 | - |
Find similar trials in Hialeah, FL
Related Studies
- Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).PHASE3 · Not Yet Recruiting · Johns Hopkins All Children's Hospital · St. Petersburg, Florida
- REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in AdultsPHASE3 · Recruiting · Regeneron Pharmaceuticals · Sheffield, Alabama
- Duke Virtual IntEgrated WorkflowNot Yet Recruiting · Duke University · Durham, North Carolina